492-26-2 Usage
Uses
Used in Pharmaceutical Industry:
(S)-1,2,3,4-Tetrahydro-4-oxo-2-quinolinecarboxylic acid is used as a precursor in the synthesis of various pharmacologically active compounds, leveraging its potential biological activities for the development of new medications.
Used in Antimicrobial Applications:
In the field of antimicrobials, (S)-1,2,3,4-Tetrahydro-4-oxo-2-quinolinecarboxylic acid is utilized for its antibacterial, antifungal, and antiviral properties, making it a promising candidate for the development of treatments against a range of infectious diseases.
Used in Cancer Treatment Research:
Within the realm of oncology, (S)-1,2,3,4-Tetrahydro-4-oxo-2-quinolinecarboxylic acid is explored for its potential use in the treatment of cancer, as it may contribute to the development of novel therapeutic strategies against this complex group of diseases.
Used in Inflammatory Disease Treatment:
(S)-1,2,3,4-Tetrahydro-4-oxo-2-quinolinecarboxylic acid is also investigated for its potential role in treating inflammatory diseases, given its demonstrated biological activities that could be harnessed to manage or alleviate inflammation.
Used in Enzyme and Receptor Inhibition:
Furthermore, (S)-1,2,3,4-Tetrahydro-4-oxo-2-quinolinecarboxylic acid is valued for its ability to act as an inhibitor of certain enzymes and receptors, which is crucial in drug discovery and development, as it can lead to the creation of targeted therapies for specific conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 492-26-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 4,9 and 2 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 492-26:
(5*4)+(4*9)+(3*2)+(2*2)+(1*6)=72
72 % 10 = 2
So 492-26-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H9NO3/c12-9-5-8(10(13)14)11-7-4-2-1-3-6(7)9/h1-4,8,11H,5H2,(H,13,14)/t8-/m0/s1
492-26-2Relevant academic research and scientific papers
Novel human lens metabolites from normal and cataractous human lenses
Mizdrak, Jasminka,Hains, Peter G.,Kalinowski, Danuta,Truscott, Roger J.W.,Davies, Michael J.,Jamie, Joanne F.
, p. 4990 - 4999 (2008/02/01)
4-(2-Aminophenyl)-4-oxobutanoic acid, 4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid and glutathionyl-kynurenine have been identified as novel metabolites in normal and cataractous human lenses following total synthesis and comparison with authentic human
Synthesis of a 9-aza analogue of eleutherol
Townsend, Norman O.,Jackson, Yvette A.
, p. 669 - 675 (2008/03/12)
A 9-aza analogue of the natural product cleutherol was synthesized by intramolecular acylation of a dihydrokynurenic acid.
2-Carboxytetrahydroquinolines. Conformational and Stereochemical Requirements for Antagonism of the Glycine Site on the NMDA Receptor
Carling, Robert W.,Leeson, Paul D.,Moseley, Angela M.,Baker, Raymond,Foster, Alan C.,et al.
, p. 1942 - 1953 (2007/10/02)
2-Carboxy-1,2,3,4-tetrahydroquinoline derivatives, derived from kynurenic acid, have been synthesized and evaluated for in vitro antagonist activity at the glycine site on the NMDA receptor. 2,3-Dihydrokynurenic acids show reduced potency relative to the
